Molar Potency Study of HM12460A in Healthy Subjects

Completed · Phase 1

Conditions studied: Healthy Volunteers

In brief

This is a phase 1 study to assess and compare molar potency of HM12460A and glargine in healthy subjects.

Key facts

Study ID

NCT03330314

Run by

Hanmi Pharmaceutical Company Limited

People needed

38

Starts

2017-10-24

Expected to finish

2018-02-08

Last updated by the study team

2020-08-12

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Females must be non-pregnant and non-lactating
• Males must be surgically sterile or using an acceptable contraceptive method

You may not qualify if…

• History of any major surgery within 6 months prior to screening
• Use of any new prescription or non-prescription drug in the last 30 days

Where it is running

• Hanmi Investigative Site — Chula Vista, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.